thiazoles has been researched along with gw 610 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradshaw, TD; Choo, HL; Leong, CO; Muruhadas, A; Randhawa, N; Stevens, MF; Tan, BS; Tiong, KH | 1 |
| Guengerich, FP; Wang, K | 1 |
| Bradshaw, TD; Citossi, F; Farmer, PB; Gaskell, M; Hose, C; Kaur, B; Kellam, B; Leong, CO; Marlow, M; Monks, A; Singh, R; Stevens, MF; Stocks, M; Stone, EL | 1 |
3 other study(ies) available for thiazoles and gw 610
| Article | Year |
|---|---|
CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Colorectal Neoplasms; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Enzyme Induction; Female; Humans; Male; Thiazoles | 2011 |
Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.
Topics: Antineoplastic Agents; Benzothiazoles; Biocatalysis; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; DNA Adducts; Humans; Kinetics; Microsomes, Liver; Oxidation-Reduction; Spectrometry, Mass, Electrospray Ionization; Thiazoles | 2012 |
Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.
Topics: Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; DNA Adducts; Drug Resistance, Neoplasm; Gene Expression Regulation; Histones; Humans; Hydrogels; Microscopy, Confocal; Prodrugs; Resveratrol; Stilbenes; Thiazoles | 2015 |